Rapid Aggravation of Rhabdomyolysis Caused by Daptomycin After Aortic Arch Replacement: A Case Report

Kenichi Takechi1, Mayuko Fujimoto1, Tomoko Abe1

  • 1Department of Anesthesia, Matsuyama Red Cross Hospital, Matsuyama, JPN.

Cureus
|March 7, 2024
PubMed

Insights

Rhabdomyolysis, a rare but serious complication of cardiothoracic surgery, can be exacerbated by daptomycin. This case highlights the need for caution when using daptomycin in patients with elevated creatine kinase levels.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Pharmacology

Background:

  • Rhabdomyolysis is a rare but severe complication following cardiothoracic surgery.
  • Daptomycin is an antibiotic used for methicillin-resistant Staphylococcus aureus (MRSA) infections, known to cause elevated creatine kinase (CK).

Observation:

  • A patient undergoing complex aortic repair developed rhabdomyolysis post-surgery.
  • Following initial improvement, empiric daptomycin was initiated for a suspected MRSA surgical site infection.
  • A significant increase in CK levels was observed after starting daptomycin, without evidence of recurrent ischemia.

Findings:

  • The patient's rhabdomyolysis, indicated by markedly elevated CK levels, worsened after daptomycin initiation.
  • Discontinuation of daptomycin led to a decrease in CK levels, suggesting a drug-induced effect.
  • The case indicates a potential link between daptomycin and exacerbation of rhabdomyolysis in post-surgical patients.

Implications:

  • Daptomycin use requires extreme caution in patients with or recovering from rhabdomyolysis, especially after cardiothoracic procedures.
  • Monitoring CK levels closely during daptomycin therapy in this population is crucial.
  • Further investigation into the mechanism of daptomycin-induced rhabdomyolysis is warranted.